Cocrystal Pharma (COCP) FCF Margin (2010 - 2026)
Cocrystal Pharma (COCP) posted FCF Margin of 1040.0% for Q1 2026, down 122.67% sequentially from 467.06% in Q4 2020.
Cocrystal Pharma (COCP) FCF Margin (2010 - 2026) Analysis & Trends
Cocrystal Pharma has reported FCF Margin for 7 years, with the latest figure at 1040.0% in Q1 2026.
- Quarterly FCF Margin changed N/A year-over-year to 1040.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 427.5% (changed N/A YoY) and the FY2020 annual result came in at 500.0%, down 47398.0% from the prior year.
- FCF Margin fell to 1040.0% in Q1 2026 per COCP's latest filing, from 467.06% in the prior quarter.
- Over five years, FCF Margin peaked at 1040.0% in Q1 2026 and troughed at 1040.0% in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | Cocrystal Pharma | 15.86 Mn | 13.54 Mn | - | -2,396.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,396.19% |
| Mar 31, 2026 | -1,040.00% |
| Dec 31, 2020 | -467.06% |
| Sep 30, 2020 | -629.86% |
| Jun 30, 2020 | -420.04% |
| Mar 31, 2020 | -494.79% |
| Dec 31, 2019 | -306.22% |
| Sep 30, 2019 | -292.28% |
| Jun 30, 2019 | -174.32% |
| Mar 31, 2019 | 39.25% |
| Jun 30, 2013 | -34.90% |
| Mar 31, 2013 | 2.71% |
| Dec 31, 2012 | 5.57% |
| Sep 30, 2012 | 7.33% |
| Jun 30, 2012 | -2.80% |
| Mar 31, 2012 | -62.05% |
| Dec 31, 2011 | -21.76% |
| Sep 30, 2011 | 16.82% |
| Jun 30, 2011 | -14.49% |
| Mar 31, 2011 | -17.41% |